세계의 태아 및 신생아 케어 장비 시장 : 시장 인사이트, 경쟁 구도, 시장 예측(2032년)

Fetal & Neonatal Care Equipment Market by Product Type (Fetal Care Equipment {Ultrasound Systems, Fetal Dopplers, Fetal MRI Systems, Fetal Monitors, and Others} and Neonatal Care Equipment {Infant Warmers, Neonatal Ventilators, Neonatal Resuscitators, Infant SpO2 Sensors, Integrated Monitoring Systems, and Others}), End-User (Hospitals, Specialty Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2032 owing to the increase in number of preterm births and technological advancements in product development

The fetal & neonatal care equipment market was valued at USD 8,276.38 million in 2024, growing at a CAGR of 8.33% during the forecast period from 2025 to 2032 to reach USD 15,616.87 million by 2032. The demand for fetal and neonatal care equipment is being significantly driven by the rising number of preterm births globally. In addition to this, the increasing prevalence of congenital anomalies and birth defects, along with continuous advancements in technology, are fueling the growth of the market. Moreover, the ongoing product developments and frequent launches by leading market players are further contributing to the expansion of the fetal and neonatal care equipment market. These factors are expected to play a pivotal role in shaping the market's positive growth trajectory during the forecast period from 2025 to 2032.

Fetal & Neonatal Care Equipment Market Dynamics:

The rising incidence of preterm births is a major driver for the growth of the fetal and neonatal care equipment market. According to UNICEF (2023), approximately 15 million babies, about one in ten are born prematurely each year worldwide.

Similarly, BLISS UK (2024) reported over 13 million preterm births annually, with the highest prevalence observed in sub-Saharan Africa and Southern Asia. The United Kingdom alone accounts for around 58,000 premature births each year.

In Australia, data from Northern Health Australia (2023) reveals that one in 12 babies is born prematurely, with the rate nearly doubling to 15% for Aboriginal babies, amounting to over 26,000 preterm births annually. Similarly, in Canada, Statistique Canada (2024) indicates that 8.3% of all births, or approximately 25,000 babies annually, are preterm. This rising trend is mirrored in other regions, creating a robust demand for advanced fetal and neonatal care equipment.

These devices are crucial in detecting risk factors associated with preterm births, such as abnormal fetal growth, shortened cervix, and other maternal or fetal complications. Early identification enables timely interventions, including the monitoring of uterine contractions and fetal distress, which can significantly reduce the risk of premature delivery and improve neonatal outcomes.

The growing prevalence of congenital anomalies and birth defects is significantly driving the market growth for fetal and neonatal care equipment. According to data from the World Health Organization (WHO) in March 2023, an estimated 8 million newborns are born with a birth defect globally each year. Alarmingly, nine out of every ten children born with serious birth defects are in low- and middle-income countries, highlighting a critical need for improved prenatal care and diagnostic tools in these regions. Fetal care devices, particularly ultrasound systems, play a pivotal role in the early detection of congenital anomalies. Ultrasound, with its high-resolution imaging capabilities, enables the identification of a wide range of fetal conditions, including cleft lip and palate, heart defects, spina bifida, hydrocephalus, and limb malformations. As the prevalence of congenital anomalies continues to rise, the demand for advanced fetal care equipment is expected to grow, further accelerating the market expansion.

Such increasing cases of preterm births and congenital anomalies is promoting key players to develop advanced devices. For instance, in September 2024, Samsung launched the HERA Z20, an advanced ultrasound system designed for OB&GYN applications. The system enhances cutting-edge AI diagnostic assistance to improve the health of both women and fetuses. It provides real-time fetal imaging and delivers six measurements from three transverse views of the fetal brain, offering comprehensive insights for better prenatal care.

Similarly, in February 2024, GE HealthCare received 510(k) clearance from the United States Food and Drug Administration (FDA) for the Novii(TM)+ Wireless Patch Solution. This advanced maternal and fetal monitoring system offers noninvasive measurement and real-time display of critical data, including fetal heart rate, maternal heart rate, and uterine activity. By providing continuous, real-time insights, the Novii(TM)+ Wireless Patch Solution enables care teams to closely monitor both maternal and fetal health during antepartum and intrapartum stages.

However, the limitations associated with fetal & neonatal care equipment and chances of nosocomial infections, among others are some of the key constraints that may limit the growth of the fetal & neonatal care equipment market.

Fetal & Neonatal Care Equipment Market Segment Analysis:

Fetal & Neonatal Care Equipment Market by Product Type (Fetal Care Equipment {Ultrasound Systems, Fetal Dopplers, Fetal MRI Systems, Fetal Monitors, and Others} and Neonatal Care Equipment {Infant Warmers, Neonatal Ventilators, Neonatal Resuscitators, Infant SpO2 Sensors, Integrated Monitoring Systems, and Others}), End-User (Hospitals, Specialty Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of the fetal & neonatal care equipment market, the ultrasound systems subcategory is estimated to account for a significant share in the fetal & neonatal care equipment market in 2024. This can be attributed to the various advantages and applications provided by the ultrasound devices. Ultrasound systems offer significant advantages and applications in fetal care, making them an indispensable tool for monitoring both fetal and maternal health throughout pregnancy. These systems provide real-time, dynamic imaging, enabling healthcare providers to visualize fetal development and movement, which is crucial for assessing fetal well-being.

Ultrasound technology serves a variety of essential purposes, including the detection of ectopic pregnancies, determination of gestational age, identification of congenital anomalies, evaluation of placental health, and monitoring of fetal position, growth, and amniotic fluid levels.

These systems also play a pivotal role in the assessment of developing fetal structures, such as the spine, hips, and brain, providing valuable insights into potential developmental concerns. Ultrasound is a standard practice during routine prenatal visits, with key applications in the first trimester for dating the pregnancy and confirming fetal viability, and in the second trimester for anomaly screening and growth assessment.

Additionally, the ability to assess fetal well-being and maternal health conditions with minimal invasiveness makes ultrasound a preferred diagnostic tool. The demand for ultrasound systems is further fueled by increasing product launches and regulatory approvals, which are enhancing the capabilities and accessibility of these devices.

For example, in November 2023, Siemens Healthineers launched the ACUSON Maple, a versatile and affordable ultrasound system that enhances diagnostic efficiency across various clinical settings. Equipped with machine learning, it automatically calculates fetal age and weight, reducing measurement time by up to 24% and enabling faster, more accurate assessments.

Similarly, Clarius Mobile Health received FDA clearance in June 2024 for its Clarius OB AI handheld ultrasound device, which automates fetal biometry measurements to estimate age, weight, and growth intervals, further advancing the capabilities of point-of-care fetal monitoring.

North America is expected to dominate the overall fetal & neonatal care equipment market:

North America is expected to dominate the fetal and neonatal care equipment market, holding the largest market share across all regions in 2024. This dominance can be attributed to several key factors, including the rising number of preterm births, the increasing prevalence of congenital anomalies, and the region's well-established, advanced healthcare infrastructure. Additionally, the ongoing technological innovations by leading industry players continue to drive the growth of the fetal and neonatal care equipment market in North America.

According to the data provided by the Centers for Disease Control and Prevention (CDC) in November 2024, preterm birth affected approximately 1 in 10 babies in the U.S. in 2022, amounting to nearly 380,000 premature births annually.

Additionally, the CDC reported in November 2024 that around 1 in every 33 babies, or approximately 120,000 infants annually, are born with congenital anomalies, highlighting the critical need for early detection and advanced care solutions. The country's robust healthcare system and access to cutting-edge medical technologies support the adoption of high-quality fetal and neonatal care equipment.

Leading companies are leveraging AI and other innovations to enhance diagnostic precision and efficiency. For example, in April 2024, GE HealthCare has introduced the Voluson Signature 20 and 18 ultrasound systems, which fully integrates artificial intelligence (AI) to enhance diagnostic capabilities. These systems leverage AI to automatically identify fetal anatomy in standard views, simplifying and accelerating fetal heart assessments by up to 48%. With AI-driven step-by-step guidance, they help healthcare providers quickly identify normal fetal heart anatomy, improving both efficiency and accuracy in prenatal care.

Moreover, in February 2023, Samsung introduced the HERA W10 Elite ultrasound system, capable of visualizing the fetal heart and brain as early as eight weeks through advanced endovaginal imaging.

Fetal & Neonatal Care Equipment Market Key Players:

Some of the key market players operating in the fetal and neonatal care equipment market include Koninklijke Philips N.V., Medtronic, GE HealthCare, Getinge, Siemens Healthineers AG, Arjo, Masimo, VYAIRE, Hamilton Medical, Fisher & Paykel Healthcare Limited, Ibis Medical, Dragerwerk AG & Co. KGaA, Nihon Kohden Corporation, SonoScape Medical Corp., MedGyn Products, Inc., Trivitron Healthcare, Nonin, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Pulsenmore Ltd., Ambu A/S, and others.

Recent Developmental Activities in the Fetal & Neonatal Care Equipment Market:

• In October 2024, Philips introduced the Philips Avent Connected Baby Monitor, featuring a mobile app designed to provide neonatal monitoring.
• In July 2024, Huntleigh, an Arjo company, announced the launch of the Smartsigns SC500 Series Vital Signs Monitor. This versatile, mains/battery-operated monitor features an 8-inch color display and offers a robust platform for monitoring vital signs, suitable for use with adult, pediatric, and neonatal patients.
• In May 2024, Masimo announced FDA clearance for Stork(TM), a baby monitoring system designed for at-home use. The FDA-cleared, over-the-counter (OTC) version of Stork monitors critical vitals, including oxygen saturation level (SpO2), pulse rate (PR), and skin temperature. The system features visual and audible alarms to notify caregivers if the baby's SpO2 or PR readings fall outside of preset ranges, ensuring timely intervention and enhanced safety.
• In May 2022, Medtronic received FDA clearance for the Nellcor(TM) OxySoft(TM) neonatal-adult SpO2 sensor, the first pulse oximetry sensor featuring a silicone adhesive designed to protect fragile newborn skin. This innovative sensor provides longer adherence, ensuring reliable oxygen saturation monitoring for both neonatal and adult patients while minimizing skin irritation.

Key Takeaways from the Fetal & Neonatal Care Equipment Market Report Study

• Market size analysis for current Fetal & Neonatal Care Equipment Market size (2024), and market forecast for 8 years (2025 to 2032)
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
• Key companies dominating the Fetal & Neonatal Care Equipment market.
• Various opportunities available for the other competitors in the Fetal & Neonatal Care Equipment Market space.
• What are the top-performing segments in 2024? How these segments will perform in 2032?
• Which are the top-performing regions and countries in the current Fetal & Neonatal Care Equipment market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for Fetal & Neonatal Care Equipment market growth in the coming future?

Target Audience who can be benefited from this Fetal & Neonatal Care Equipment Market Report Study

• Fetal & Neonatal Care Equipment product providers
• Research organizations and consulting companies
• Fetal & Neonatal Care Equipment related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and Traders dealing in Fetal & Neonatal Care Equipment
• Various end-users who want to know more about the Fetal & Neonatal Care Equipment Market and the latest technological developments in the Fetal & Neonatal Care Equipment Market.

Frequently Asked Questions for the Fetal & Neonatal Care Equipment Market:

1. What are Fetal & Neonatal Care Equipment?

• Fetal and neonatal care equipment refers to medical devices used to monitor, diagnose, and treat the health of fetuses and newborns. These include ultrasound systems, fetal heart rate monitors, neonatal incubators, and respiratory support devices, which help manage conditions like preterm birth, congenital anomalies, and other medical complications.

2. What is the market for Fetal & Neonatal Care Equipment?

• The fetal & neonatal care equipment market was valued at USD 8,276.38 million in 2024, growing at a CAGR of 8.33% during the forecast period from 2025 to 2032 to reach USD 15,616.87 million by 2032.

3. What are the drivers for the Fetal & Neonatal Care Equipment market?

• The fetal and neonatal care equipment market is slated to witness prosperity owing to factors such as the rising number of preterm births globally. In addition to this, the increasing prevalence of congenital anomalies and birth defects, along with continuous advancements in technology, are fueling the growth of the market. Moreover, the ongoing product development and frequent launches by leading industry players are further contributing to the expansion of the fetal and neonatal care equipment market. These factors are expected to play a pivotal role in shaping the market's positive growth trajectory during the forecast period from 2025 to 2032.

4. Who are the key players operating in the Fetal & Neonatal Care Equipment market?

• Some of the key market players operating in the fetal and neonatal care equipment market include Koninklijke Philips N.V., Medtronic, GE HealthCare, Getinge, Siemens Healthineers AG, Arjo, Masimo, VYAIRE, Hamilton Medical, Fisher & Paykel Healthcare Limited, Ibis Medical, Dragerwerk AG & Co. KGaA, Nihon Kohden Corporation, SonoScape Medical Corp., MedGyn Products, Inc., Trivitron Healthcare, Nonin, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Pulsenmore Ltd., Ambu A/S, and others.

5. Which region has the highest share in the Fetal & Neonatal Care Equipment market?

• North America is expected to dominate the fetal and neonatal care equipment market, holding the largest market share across all regions in 2024. This dominance can be attributed to several key factors, including the rising number of preterm births, the increasing prevalence of congenital anomalies, and the region's well-established, advanced healthcare infrastructure. Additionally, ongoing technological innovations by leading industry players continue to drive the growth of the fetal and neonatal care equipment market in North America.

Table of Contents

1. Fetal & Neonatal Care Equipment Market Report Introduction

• 1.1. Scope of the Study
• 1.2. Market Segmentation
• 1.3. Market Assumption

2. Fetal & Neonatal Care Equipment Market Executive Summary

• 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

• 4.1. The United States
• 4.2. Europe
• 4.3. Japan
• 4.4. China

5. Fetal & Neonatal Care Equipment Market Key Factors Analysis

• 5.1. Fetal & Neonatal Care Equipment Market Drivers
  • 5.1.1. Increase in the number of preterm births
  • 5.1.2. Growing prevalence of congenital anomalies
  • 5.1.3. Increasing product development and launches activities by key players
• 5.2. Fetal & Neonatal Care Equipment Market Restraints and Challenges
  • 5.2.1. Limitations associated with fetal & neonatal care equipment
  • 5.2.2. Chances of nosocomial infections
• 5.3. Fetal & Neonatal Care Equipment Market Opportunity
  • 5.3.1. The integration of advanced technologies such as artificial intelligence (AI) and machine learning into fetal and neonatal care equipment

6. Fetal & Neonatal Care Equipment Market Porter's Five Forces Analysis

• 6.1. Bargaining Power of Suppliers
• 6.2. Bargaining Power of Consumers
• 6.3. Threat of New Entrants
• 6.4. Threat of Substitutes
• 6.5. Competitive Rivalry

7. Fetal & Neonatal Care Equipment Market Assessment

• 7.1. By Product Type
  • 7.1.1. Fetal Care Equipment
    • 7.1.1.1. Ultrasound Systems
    • 7.1.1.2. Fetal Dopplers
    • 7.1.1.3. Fetal MRI Systems
    • 7.1.1.4. Fetal Monitors
    • 7.1.1.5. Others
  • 7.1.2. Neonatal Care Equipment
    • 7.1.2.1. Infant Warmers
    • 7.1.2.2. Neonatal Ventilators
    • 7.1.2.3. Neonatal Resuscitators
    • 7.1.2.4. Infant SpO2 Sensors
    • 7.1.2.5. Integrated Monitoring Systems
    • 7.1.2.6. Others
• 7.2. By End-User
  • 7.2.1. Hospitals
  • 7.2.2. Specialty Clinics
  • 7.2.3. Others
• 7.3. By Geography
  • 7.3.1. North America
    • 7.3.1.1. United States Fetal & Neonatal Care Equipment Market Size in USD million (2022-2032)
    • 7.3.1.2. Canada Fetal & Neonatal Care Equipment Market Size in USD million (2022-2032)
    • 7.3.1.3. Mexico Fetal & Neonatal Care Equipment Market Size in USD million (2022-2032)
  • 7.3.2. Europe
    • 7.3.2.1. France Fetal & Neonatal Care Equipment Market Size in USD million (2022-2032)
    • 7.3.2.2. Germany Fetal & Neonatal Care Equipment Market Size in USD million (2022-2032)
    • 7.3.2.3. United Kingdom Fetal & Neonatal Care Equipment Market Size in USD million (2022-2032)
    • 7.3.2.4. Italy Fetal & Neonatal Care Equipment Market Size in USD million (2022-2032)
    • 7.3.2.5. Spain Fetal & Neonatal Care Equipment Market Size in USD million (2022-2032)
    • 7.3.2.6. Rest of Europe Fetal & Neonatal Care Equipment Market Size in USD million (2022-2032)
  • 7.3.3. Asia-Pacific
    • 7.3.3.1. China Fetal & Neonatal Care Equipment Market Size in USD million (2022-2032)
    • 7.3.3.2. Japan Fetal & Neonatal Care Equipment Market Size in USD million (2022-2032)
    • 7.3.3.3. India Fetal & Neonatal Care Equipment Market Size in USD million (2022-2032)
    • 7.3.3.4. Australia Fetal & Neonatal Care Equipment Market Size in USD million (2022-2032)
    • 7.3.3.5. South Korea Fetal & Neonatal Care Equipment Market Size in USD million (2022-2032)
    • 7.3.3.6. Rest of Asia-Pacific Fetal & Neonatal Care Equipment Market Size in USD million (2022-2032)
  • 7.3.4. Rest of the World (RoW)
    • 7.3.4.1. Middle East Fetal & Neonatal Care Equipment Market Size in USD million (2022-2032)
    • 7.3.4.2. Africa Fetal & Neonatal Care Equipment Market Size in USD million (2022-2032)
    • 7.3.4.3. South America Fetal & Neonatal Care Equipment Market Size In USD Million (2022-2032)

8. Fetal & Neonatal Care Equipment Market Company and Product Profiles

• 8.1. Koninklijke Philips N.V.
  • 8.1.1. Company Overview
  • 8.1.2. Company Snapshot
  • 8.1.3. Financial Overview
  • 8.1.4. Product Listing
  • 8.1.5. Entropy
• 8.2. Medtronic
  • 8.2.1. Company Overview
  • 8.2.2. Company Snapshot
  • 8.2.3. Financial Overview
  • 8.2.4. Product Listing
  • 8.2.5. Entropy
• 8.3. GE HealthCare
  • 8.3.1. Company Overview
  • 8.3.2. Company Snapshot
  • 8.3.3. Financial Overview
  • 8.3.4. Product Listing
  • 8.3.5. Entropy
• 8.4. Getinge
  • 8.4.1. Company Overview
  • 8.4.2. Company Snapshot
  • 8.4.3. Financial Overview
  • 8.4.4. Product Listing
  • 8.4.5. Entropy
• 8.5. Siemens Healthineers AG
  • 8.5.1. Company Overview
  • 8.5.2. Company Snapshot
  • 8.5.3. Financial Overview
  • 8.5.4. Product Listing
  • 8.5.5. Entropy
• 8.6. Arjo
  • 8.6.1. Company Overview
  • 8.6.2. Company Snapshot
  • 8.6.3. Financial Overview
  • 8.6.4. Product Listing
  • 8.6.5. Entropy
• 8.7. Masimo
  • 8.7.1. Company Overview
  • 8.7.2. Company Snapshot
  • 8.7.3. Financial Overview
  • 8.7.4. Product Listing
  • 8.7.5. Entropy
• 8.8. VYAIRE
  • 8.8.1. Company Overview
  • 8.8.2. Company Snapshot
  • 8.8.3. Financial Overview
  • 8.8.4. Product Listing
  • 8.8.5. Entropy
• 8.9. Hamilton Medical
  • 8.9.1. Company Overview
  • 8.9.2. Company Snapshot
  • 8.9.3. Financial Overview
  • 8.9.4. Product Listing
  • 8.9.5. Entropy
• 8.10. Fisher & Paykel Healthcare Limited
  • 8.10.1. Company Overview
  • 8.10.2. Company Snapshot
  • 8.10.3. Financial Overview
  • 8.10.4. Product Listing
  • 8.10.5. Entropy
• 8.11. Ibis Medical
  • 8.11.1. Company Overview
  • 8.11.2. Company Snapshot
  • 8.11.3. Financial Overview
  • 8.11.4. Product Listing
  • 8.11.5. Entropy
• 8.12. Dragerwerk AG & Co. KGaA
  • 8.12.1. Company Overview
  • 8.12.2. Company Snapshot
  • 8.12.3. Financial Overview
  • 8.12.4. Product Listing
  • 8.12.5. Entropy
• 8.13. Nihon Kohden Corporation
  • 8.13.1. Company Overview
  • 8.13.2. Company Snapshot
  • 8.13.3. Financial Overview
  • 8.13.4. Product Listing
  • 8.13.5. Entropy
• 8.14. SonoScape Medical Corp.
  • 8.14.1. Company Overview
  • 8.14.2. Company Snapshot
  • 8.14.3. Financial Overview
  • 8.14.4. Product Listing
  • 8.14.5. Entropy
• 8.15. MedGyn Products, Inc.
  • 8.15.1. Company Overview
  • 8.15.2. Company Snapshot
  • 8.15.3. Financial Overview
  • 8.15.4. Product Listing
  • 8.15.5. Entropy
• 8.16. Trivitron Healthcare
  • 8.16.1. Company Overview
  • 8.16.2. Company Snapshot
  • 8.16.3. Financial Overview
  • 8.16.4. Product Listing
  • 8.16.5. Entropy
• 8.17. Nonin
  • 8.17.1. Company Overview
  • 8.17.2. Company Snapshot
  • 8.17.3. Financial Overview
  • 8.17.4. Product Listing
  • 8.17.5. Entropy
• 8.18. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 8.18.1. Company Overview
  • 8.18.2. Company Snapshot
  • 8.18.3. Financial Overview
  • 8.18.4. Product Listing
  • 8.18.5. Entropy
• 8.19. Pulsenmore Ltd.
  • 8.19.1. Company Overview
  • 8.19.2. Company Snapshot
  • 8.19.3. Financial Overview
  • 8.19.4. Product Listing
  • 8.19.5. Entropy
• 8.20. Ambu A/S
  • 8.20.1. Company Overview
  • 8.20.2. Company Snapshot
  • 8.20.3. Financial Overview
  • 8.20.4. Product Listing
  • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us